Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Bio-Recovery Inc.
WARNING LETTER
•Bio-Recovery Inc.•May 17, 2013

Bio-Recovery Inc. – FDA Warning Letter, May 17, 2013

Record Details

An FDA inspection of Bio-Recovery, Inc. (Minneapolis, MN) in May 2013 identified significant violations. The firm, a dietary supplement distributor, was cited for marketing unapproved new drugs and numerous Current Good Manufacturing Practice (CGMP) deficiencies. Products like Bio-Lithium, Niacinamide, Bio-Aminos, and CoQ-10 are considered unapproved new drugs (21 U.S.C. § 321(g)(1)(B), § 321(p)) due to therapeutic claims on the company's website for conditions such as alcoholism, cancer, and heart disorders. These products are also misbranded (21 U.S.C. § 352(f)(1)) lacking adequate directions for use. Furthermore, the firm's dietary supplements are adulterated (21 U.S.C. § 342(g)(1)) due to CGMP violations (21 CFR Part 111). Deficiencies include failing to identify quality control personnel and establish written QC procedures (21 CFR 111.12(b), 111.103, 111.140(b)(1)), not collecting reserve samples (21 CFR 111.83(a)), and lacking written procedures for packaging/labeling (21 CFR 111.403), holding/distributing (21 CFR 111.453), returned products (21 CFR 111.503), and product complaints (21 CFR 111.553). The firm's stated unawareness of regulations and lack of records underscore systemic quality control issues. As the distributor, Bio-Recovery holds ultimate responsibility for CGMP compliance. The FDA requires a written response within 15 working days detailing corrective actions to prevent further regulatory action, including potential seizure, injunction, and re-inspection fees.

Company
Bio-Recovery Inc.
Inspection date
May 17, 2013
Product type
Food
Office
Minneapolis District Office
Person
  • Michael Dutcher (Acting Assistant Commissioner)
View Company Profile

ID · 72f21d8d-8b60-4913-a4be-b08cdbc3e559

Violation Codes8
21 CFR 11121 U.S.C. 342(g)(1)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 379j-3121 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Other documents for Bio-Recovery Inc.
  • 483 - 2018-07-24July 24, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bio-Recovery Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.